Absence of heart failure in severe cardiac and autonomic amyloidosis: The essential role of sympathetic activation and venous tone in the development of the congestive heart failure syndrome

Congestive Heart Failure

Volumn 15, Issue 6, 2009, Pages 288-290

  Abramov, Dmitry ^a   Weimer, Louis H ^b   Marboe, Charles C ^c   Shimbo, Daichi ^a   King, Donald L ^a   Maurer, Mathew S ^a  

^a Division of Cardiology   (United States)

^b Department of Neurology ^*  (United States)

^c NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; FINASTERIDE; FLUDROCORTISONE; IMMUNOGLOBULIN G; MIDODRINE; PAROXETINE; POTASSIUM CHLORIDE; PYRIDOSTIGMINE; SODIUM CHLORIDE;

ADRENERGIC STIMULATION; AGED; AMYLOID CARDIOMYOPATHY; AMYLOIDOSIS; ARTICLE; AUTONOMIC NEUROPATHY; BLOOD PRESSURE MEASUREMENT; CARDIOMYOPATHY; CASE REPORT; CONGESTIVE HEART FAILURE; CREATININE BLOOD LEVEL; DIASTOLIC DYSFUNCTION; DIZZINESS; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FATIGUE; GAIT DISORDER; HEART CATHETERIZATION; HEART EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE BIOPSY; HEART RATE VARIABILITY; HEMATOCRIT; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; MALE; ORTHOSTATIC HYPOTENSION; PERICARDIAL EFFUSION; PLEURA EFFUSION; PRIORITY JOURNAL; PROTEINURIA; SYNCOPE; THORAX RADIOGRAPHY; VALSALVA MANEUVER;

AGED; AMYLOIDOSIS; AUTONOMIC NERVOUS SYSTEM DISEASES; HEART DISEASES; HEART FAILURE; HUMANS; MALE; RISK FACTORS; SYMPATHETIC NERVOUS SYSTEM; SYNDROME; VEINS;

EID: 70649102369     PISSN: 15275299     EISSN: 17517133     Source Type: Journal    
DOI: 10.1111/j.1751-7133.2009.00058.x     Document Type: Article

References (10)

1. Shah KB, Inoue Y, Mehra MR. Amyloidosis and the heart: a comprehensive review. Arch Intern Med 2006, 166:1805-1813.
2. Dubrey SW, Cha K, Anderson J. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. QJM 1998, 91:141-157.
3. Arques S, Ambrosi P, Gelisse R. Hypoalbuminemia in elderly patients with acute diastolic heart failure. J Am Coll Cardiol 2003, 42:712-716.
4. Packer M. Neurohormonal interactions and adaptations in congestive heart failure. Circulation 1988, 77:721-730.
5. Burkhoff D, Tyberg JV. Why does pulmonary venous pressure rise after onset of LV dysfunction: a theoretical analysis. Am J Physiol 1993, 265:H1819-H1828.
6. Burch GE. The role of the central nervous system in chronic congestive heart failure. Am Heart J 1978, 95:255-261.
7. Carabello BA, Nakano K, Corin W. Left ventricular function in experimental volume overload hypertrophy. Am J Physiol 1989, 256:H974-H981.
8. Rajkumar SV, Gertz MA, Kyle RA. Prognosis of patients with primary systemic amyloidosis who present with dominant neuropathy. Am J Med 1998, 104:232-237.
9. Bernardi L, Passino C, Porta C. Widespread cardiovascular autonomic dysfunction in primary amyloidosis: does spontaneous hyperventilation have a compensatory role against postural hypotension?. Heart 2002, 88:615-621.
10. Volpi A, Cavalli A, Maggioni AP. Cardiac amyloidosis involving the conduction system and the aortocoronary neuroreceptors. Clinicopathologic correlates. Chest 1986, 90:619-621.